The C-reactive Protein (CRP) Point of Care Testing (POCT) Implementation to Adult Patients Presenting With Symptoms of the Acute Respiratory Tract Infection (ARTI) in Eight Primary Health Care (PHC) in Jakarta.

Recruiting N/A Interventional Study
Adults Acute Respiratory Tract Infection Antibiotic Prescriptions
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Diagnostic
Participants needed
2,544 (estimated)
Sponsor
Oxford University Clinical Research Unit Indonesia · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Antimicrobial resistance (AMR) has emerged as one of the most pressing global health challenges of the 21st century, particularly Indonesia is projected to be among the five nations globally with the highest percentage increase in antimicrobial consumption by 2030. Primary care settings represent the most critical implementation point for addressing inappropriate antibiotic use. ARTI constitutes t…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Adults aged ≥18 years. 2. Presenting to the PHC site for the first consultation of the current episode of Acute-Respiratory Tract Infections (ARTI). 3. Reporting at least one of the following symptoms or clinical signs within the past 5 days: cough, rhinitis (e.g., sneezing, …
Contacts

Robert Sinto, MD, DPhil

+622123599099

rsinto@oucru.org

CONTACT

Raph L Hamers, MD, PhD

+622123599099

rhamers@oucru.org

CONTACT